Annual CFO
-$235.05 M
+$81.17 M+25.67%
31 December 2023
Summary:
bluebird bio annual cash flow from operations is currently -$235.05 million, with the most recent change of +$81.17 million (+25.67%) on 31 December 2023. During the last 3 years, it has risen by +$235.31 million (+50.03%). BLUE annual CFO is now -640.96% below its all-time high of $43.45 million, reached on 31 December 2013.BLUE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$68.93 M
-$2.68 M-4.04%
30 September 2024
Summary:
bluebird bio quarterly cash flow from operations is currently -$68.93 million, with the most recent change of -$2.68 million (-4.04%) on 30 September 2024. Over the past year, it has dropped by -$18.88 million (-37.72%). BLUE quarterly CFO is now -204.41% below its all-time high of $66.02 million, reached on 31 March 2013.BLUE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$263.99 M
-$18.88 M-7.70%
30 September 2024
Summary:
bluebird bio TTM cash flow from operations is currently -$263.99 million, with the most recent change of -$18.88 million (-7.70%) on 30 September 2024. Over the past year, it has dropped by -$63.54 million (-31.70%). BLUE TTM CFO is now -615.87% below its all-time high of $51.17 million, reached on 31 March 2013.BLUE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLUE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.7% | -37.7% | -31.7% |
| 3 y3 years | +50.0% | +53.1% | +59.5% |
| 5 y5 years | +43.1% | +39.2% | +50.7% |
BLUE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +63.0% | -252.8% | +53.1% | -31.7% | +59.5% |
| 5 y | 5 years | at high | +63.0% | -273.4% | +66.6% | -31.7% | +59.6% |
| alltime | all time | -641.0% | +63.0% | -204.4% | +66.6% | -615.9% | +59.6% |
Bluebird Bio Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$68.93 M(+4.0%) | -$263.99 M(+7.7%) |
| June 2024 | - | -$66.25 M(-11.3%) | -$245.12 M(+2.8%) |
| Mar 2024 | - | -$74.68 M(+37.9%) | -$238.36 M(+1.4%) |
| Dec 2023 | -$235.05 M(-25.7%) | -$54.14 M(+8.2%) | -$235.05 M(+17.3%) |
| Sept 2023 | - | -$50.05 M(-15.9%) | -$200.45 M(-11.9%) |
| June 2023 | - | -$59.50 M(-16.6%) | -$227.42 M(-13.3%) |
| Mar 2023 | - | -$71.36 M(+265.2%) | -$262.28 M(-17.1%) |
| Dec 2022 | -$316.22 M(-50.3%) | -$19.54 M(-74.6%) | -$316.22 M(-27.5%) |
| Sept 2022 | - | -$77.03 M(-18.4%) | -$436.40 M(-13.8%) |
| June 2022 | - | -$94.36 M(-24.7%) | -$506.32 M(-9.2%) |
| Mar 2022 | - | -$125.30 M(-10.3%) | -$557.61 M(-12.3%) |
| Dec 2021 | -$635.64 M(+35.1%) | -$139.72 M(-4.9%) | -$635.64 M(-2.4%) |
| Sept 2021 | - | -$146.94 M(+0.9%) | -$651.11 M(-0.3%) |
| June 2021 | - | -$145.65 M(-28.4%) | -$652.95 M(+39.7%) |
| Mar 2021 | - | -$203.33 M(+31.0%) | -$467.56 M(-0.6%) |
| Dec 2020 | -$470.35 M(-16.7%) | -$155.19 M(+4.3%) | -$470.35 M(-0.8%) |
| Sept 2020 | - | -$148.78 M(-474.4%) | -$474.13 M(+8.1%) |
| June 2020 | - | $39.74 M(-119.3%) | -$438.74 M(-28.8%) |
| Mar 2020 | - | -$206.12 M(+29.7%) | -$616.35 M(+9.2%) |
| Dec 2019 | -$564.38 M(+36.5%) | -$158.98 M(+40.2%) | -$564.38 M(+5.5%) |
| Sept 2019 | - | -$113.38 M(-17.8%) | -$535.14 M(+7.8%) |
| June 2019 | - | -$137.87 M(-10.6%) | -$496.23 M(+8.2%) |
| Mar 2019 | - | -$154.15 M(+18.8%) | -$458.76 M(+11.0%) |
| Dec 2018 | -$413.43 M | -$129.73 M(+74.2%) | -$413.43 M(+9.1%) |
| Sept 2018 | - | -$74.47 M(-25.8%) | -$379.07 M(+5.0%) |
| June 2018 | - | -$100.40 M(-7.7%) | -$360.94 M(+14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$108.82 M(+14.1%) | -$314.07 M(+11.9%) |
| Dec 2017 | -$280.55 M(+47.9%) | -$95.38 M(+69.3%) | -$280.55 M(+10.3%) |
| Sept 2017 | - | -$56.34 M(+5.2%) | -$254.28 M(+7.1%) |
| June 2017 | - | -$53.53 M(-28.9%) | -$237.38 M(+4.0%) |
| Mar 2017 | - | -$75.30 M(+9.0%) | -$228.18 M(+20.3%) |
| Dec 2016 | -$189.65 M(+92.7%) | -$69.11 M(+75.2%) | -$189.65 M(+23.4%) |
| Sept 2016 | - | -$39.44 M(-11.0%) | -$153.63 M(+7.2%) |
| June 2016 | - | -$44.33 M(+20.6%) | -$143.25 M(+29.0%) |
| Mar 2016 | - | -$36.77 M(+11.1%) | -$111.04 M(+12.8%) |
| Dec 2015 | -$98.43 M(+64.9%) | -$33.09 M(+13.8%) | -$98.43 M(+21.5%) |
| Sept 2015 | - | -$29.07 M(+139.9%) | -$81.01 M(+11.4%) |
| June 2015 | - | -$12.12 M(-49.8%) | -$72.71 M(+1.1%) |
| Mar 2015 | - | -$24.16 M(+54.2%) | -$71.92 M(+20.5%) |
| Dec 2014 | -$59.69 M(-237.4%) | -$15.66 M(-24.6%) | -$59.69 M(+20.6%) |
| Sept 2014 | - | -$20.77 M(+83.4%) | -$49.48 M(+31.7%) |
| June 2014 | - | -$11.32 M(-5.1%) | -$37.57 M(+8.9%) |
| Mar 2014 | - | -$11.93 M(+118.8%) | -$34.50 M(-179.4%) |
| Dec 2013 | $43.45 M(-306.5%) | -$5.46 M(-38.4%) | $43.45 M(+2.8%) |
| Sept 2013 | - | -$8.86 M(+7.4%) | $42.27 M(-9.9%) |
| June 2013 | - | -$8.25 M(-112.5%) | $46.91 M(-8.3%) |
| Mar 2013 | - | $66.02 M(-1094.8%) | $51.17 M(-343.2%) |
| Dec 2012 | -$21.04 M(+72.3%) | -$6.64 M(+57.1%) | -$21.04 M(+46.1%) |
| Sept 2012 | - | -$4.22 M(+6.0%) | -$14.41 M(+41.5%) |
| June 2012 | - | -$3.98 M(-35.7%) | -$10.19 M(+64.3%) |
| Mar 2012 | - | -$6.20 M | -$6.20 M |
| Dec 2011 | -$12.22 M | - | - |
FAQ
- What is bluebird bio annual cash flow from operations?
- What is the all time high annual CFO for bluebird bio?
- What is bluebird bio annual CFO year-on-year change?
- What is bluebird bio quarterly cash flow from operations?
- What is the all time high quarterly CFO for bluebird bio?
- What is bluebird bio quarterly CFO year-on-year change?
- What is bluebird bio TTM cash flow from operations?
- What is the all time high TTM CFO for bluebird bio?
- What is bluebird bio TTM CFO year-on-year change?
What is bluebird bio annual cash flow from operations?
The current annual CFO of BLUE is -$235.05 M
What is the all time high annual CFO for bluebird bio?
bluebird bio all-time high annual cash flow from operations is $43.45 M
What is bluebird bio annual CFO year-on-year change?
Over the past year, BLUE annual cash flow from operations has changed by +$81.17 M (+25.67%)
What is bluebird bio quarterly cash flow from operations?
The current quarterly CFO of BLUE is -$68.93 M
What is the all time high quarterly CFO for bluebird bio?
bluebird bio all-time high quarterly cash flow from operations is $66.02 M
What is bluebird bio quarterly CFO year-on-year change?
Over the past year, BLUE quarterly cash flow from operations has changed by -$18.88 M (-37.72%)
What is bluebird bio TTM cash flow from operations?
The current TTM CFO of BLUE is -$263.99 M
What is the all time high TTM CFO for bluebird bio?
bluebird bio all-time high TTM cash flow from operations is $51.17 M
What is bluebird bio TTM CFO year-on-year change?
Over the past year, BLUE TTM cash flow from operations has changed by -$63.54 M (-31.70%)